Due to their ability to detoxify toxic aldehydes protecting cancer cells from toxic ROS levels, ALDH was attributed to conferring chemotherapy drug-resistance, making ALDH inhibitors promising drugs against NPC [76]. This evidence concerns the gene LDHA and nasopharyngeal carcinoma.